Bryan D Fleming

Years Active: 2020-2022
Publications (10 Years): 4

National Cancer Institute

University of Maryland at College Park (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Institute

United States

Postdoc Fellow :: LMB

Education History

University of Maryland at College Park

United States

PHD :: CBMG

University of Maryland at College Park

United States

BSC :: CBMG

Publications

Bryan D Fleming, Mitchell Ho
Generation of Single-Domain Antibody-Based Recombinant Immunotoxins. Methods in molecular biology (Clifton, N.J.) 2446 (2022)
Ying Fu, Juliana da Fonseca Rezende E Mello, Bryan D Fleming, Alex Renn, Catherine Z Chen, Xin Hu, Miao Xu, Kirill Gorshkov, Quinlin Hanson, Wei Zheng, Emily M Lee, Lalith Perera, Robert Petrovich, Manisha Pradhan, Richard T Eastman, Zina Itkin, Thomas B Stanley, Allen L Hsu, Venkata Dandey, Kedar Sharma, William Gillette, Troy Taylor, Nitya Ramakrishnan, Shelley Perkins, Dominic Esposito, Eunkeu Oh, Kimihiro Susumu, Mason Wolak, Marc Ferrer, Matthew D Hall, Mario J Borgnia, Anton Simeonov
A humanized nanobody phage display library yields potent binders of SARS CoV-2 spike. PloS one 17 (8) (2022)
Bryan D Fleming, Mitchell Ho
Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update. Biomolecules 10 (6) (2020)
Bryan D Fleming, Daniel J Urban, Matthew D Hall, Thomas Longerich, Tim F Greten, Ira Pastan, Mitchell Ho
Engineered Anti-GPC3 Immunotoxin, HN3-ABD-T20, Produces Regression in Mouse Liver Cancer Xenografts Through Prolonged Serum Retention. Hepatology (Baltimore, Md.) 71 (5) (2020)

Bryan D Fleming.css-eqlu8i{font-size:small;padding-left:4px;}